| Back to the Virtual Exhibit Hall | |||||||||||||||||||||||||
ADC Therapeutics SA operates as a clinical-stage oncology drug discovery and development company. The Company focuses on advancing highly potent and targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. ADC Therapeutics serves customers in the United States, Switzerland, and the United Kingdom. |
| |||||||||||||||||||||||||
Dawn Fratto Hematology Therapeutic Specialist - Pittsburgh ADC Therapeutics 412-606-8350
| ZYNLONTA_Getting_Started_Brochure.pdf correct zynlonta-dosing-and-administration-guide-0421.pdf
|
| ||||||||||||||||||||||||
|
|